The diagnosis and treatment of rhinosinusitis during pregnancy and lactation

Immunology and Allergy Clinics of North America

Volumn 20, Issue 4, 2000, Pages 807-830

  Incaudo, Gary A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE; BUDESONIDE; CETIRIZINE; CHLORPHENIRAMINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DIPHENHYDRAMINE; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE; HYDROXYZINE; LORATADINE; MOMETASONE FUROATE; OXYMETAZOLINE; PHENYLEPHRINE; PROMETHAZINE; PSEUDOEPHEDRINE; TRIPELENNAMINE;

AIR POLLUTION; ALLERGIC RHINITIS; ANAMNESIS; ATOPY; AUDITORY TUBE; BREAST FEEDING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG SAFETY; EARLY DIAGNOSIS; GASTROSCHISIS; HUMAN; IMMUNOTHERAPY; LABORATORY TEST; LACTATION; NONHUMAN; NOSE CONGESTION; NOSE MUCOSA; PHYSICAL EXAMINATION; PREGNANCY; PRIORITY JOURNAL; REVIEW; SINUSITIS; TERATOGENICITY; VIRUS INFECTION;

EID: 0033779054     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70184-3     Document Type: Article

References (105)

1. Transfer of drugs and other chemicals into human milk
2. First-trimester drug use and congenital disorders
3. Fetal heart rate changes following maternal administration of a nasal decongestant
4. Nasal congestion during pregnancy
5. Use of A-mode ultrasound for diagnosis of sinus disease in young children
6. Safety of the new quinolones in pregnancy
7. Morphologic changes in the developing rat placenta following prednisolone administration
8. Maternal corticosteroid use and risk of selected congenital anomalies
9. Placental transmission of antibiotics
10. Antibiotic use in pregnancy
11. Eustachian tube and nasal function during pregnancy: A prospective study
12. Pregnancy outcome following maternal exposure to corticosteroids: A prospective controlled cohort study and meta-analysis of epidemiological studies
13. Drug therapy in the nursing mother
14. Antibiotic selection in obstetric patients
15. Characteristics of the course and treatment of inflammatory nasal and paranasal sinus diseases in pregnancy
16. Prospective controlled study of hydroxyzine and cetirizine in pregnancy
17. A prospective controlled multicentre study of clarithromycin in pregnancy
18. Serum level of placental growth hormone is raised in pregnancy rhinitis
19. Nasal congestion during pregnancy
20. The incidence of pregnancy rhinitis
21. Infantile multicystic encephalomalacia after maternal bee sting anaphylaxis during pregnancy
22. Double-blind evaluation of hydroxyzine as an antiemetic in pregnancy
23. Maternal immunologic changes during pregnancy: A critical appraisal
24. Maternal immune function during pregnancy
25. Prenatal exposure to ionizing radiation: Sources, effects and regulatory aspects
26. Labeling and prescription drug advertising: Content and format for labeling for human prescription drugs (final rule)
27. The assessment of nasal airflow: A review of past and present methods
28. The experimental production of cleft palate with cortisone and other hormones
29. The risks and benefits of antimicrobial therapy in pregnancy
30. Oral antihistamines/decongestants and breastfeeding
31. Pregnancy and asthma
32. Expression of histamine receptors in nasal epithelial cells and endothelial cells: The effects of sex hormones
33. Effect of sex hormones on eosinophilic inflammation in nasal mucosa
34. Cyclical changes in female mucous
35. The lactating allergic patient: Which drugs cause concern for the infant?
36. ENT medications in pregnancy
37. Drugs and breastfeeding
38. The diagnosis and treatment of rhinosinusitis during pregnancy and lactation
39. The pathophysiology and treatment of sinusitis
40. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication
41. First-trimester drug use and congenital disorders
42. Replacement estrogens and endometrial cancer
43. Congenital malformations after the use of inhaled budesonide in early pregnancy
44. Drowsiness due to clemastine transmitted in breast milk
45. Effects of female hormones on the muscarinic and alpha-1 receptors of the nasal mucosa: An experimental study in guinea pigs
46. Ultrasound screening for sinus disease
47. Rhinitis during pregnancy and rhinitis medicamentosa
48. A review of the current guidelines for allergic rhinitis and asthma
49. When allergies and asthma complicate pregnancy
50. Fluoroquinolone toxicity profiles: A review focusing on newer agents
51. Fatalities from immunotherapy and skin testing
52. Pharmacokinetic changes during pregnancy and their clinical relevance
53. Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study
54. Drug use during lactation
55. Rhinitis of pregnancy
56. Intranasal steroid injection during pregnancy
57. The physiological and pathological relations between the nose and the sexual appearance of man
58. Treating allergic rhinitis in pregnancy
59. Therapeutic considerations in pregnancy and lactation
60. Indications for allergen immunotherapy during pregnancy
61. The safety of immunotherapy during pregnancy
62. Association between drugs administered during pregnancy and congenital abnormalities of the fetus
63. The effects of in utero diagnostic x-radiation on the development of preschool-age children
64. The safety of astemizole during pregnancy
65. Probable benedryl withdrawal manifestation in a newborn infant
66. Ofloxacin during the second trimester of pregnancy
67. Pharmacokinetics of antibiotics in pregnancy and labour
68. The frequency of patulous eustachian tubes in pregnancy
69. Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride
70. Uterine and fetal Doppler flow changes from a single dose of a long-acting intranasal decongestant
71. Corticosteroids during pregnancy and oral clefts: A case-control study
72. Correlation between A-mode ultrasound and radiography in the diagnosis of maxillary sinusitis
73. Exogenous hormones and other drug exposures of children with congenital heart disease
74. Cleft palate and maternal diphenhydramine intake
75. Asthma treatment during pregnancy: What can be safely taken?
76. Special consideration for the pregnant woman and senior citizen with airway disease
77. Asthma and allergy in pregnancy
78. The cause and management of asthma and allergic diseases during pregnancy
79. Diagnosis and management of rhinitis during pregnancy
80. Antihistamines and pregnancy
81. Ciprofloxacin: Toxicologic evaluation of additional safety data
82. Considerations of antibiotic therapy during pregnancy
83. The use of antibiotics in perinatal infections
84. Evaluation of bronpheniramine safety in pregnancy
85. Blinded comparison of maxillary sinus radiography and ultrasound for diagnosis of sinusitis
86. Effect of a single dose of oral pseudoephedrine on uterine and fetal Doppler blood flow
87. Rhinitis during pregnancy
88. Practice parameters for the diagnosis and treatment of asthma. V: Diagnosis and evaluation
89. An experimental study of the influence of the endocrine system on the nasal respiratory mucosa
90. Allergic diseases - Especially on the relation of pregnancy
91. FDA classification of drugs for teratogenic risk
92. Safety of radiographic imaging during pregnancy
93. The human respiratory nasal mucosa in pregnancy
94. The human respiratory nasal mucosa in females using contraceptive pills
95. Maternal medications and environmental exposures as risk factors for gastroschisis
96. Managing pregnancy-related nocturnal nasal congestion: The external nasal dilator
97. First trimester maternal medications use in relation to gastroschisis
98. Use of sodium cromoglycate during pregnancy
99. Comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies
100. Prenatal antihistamine exposure and retrolental fibroplasia
101. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy